High Tide Past Earnings Performance
Past criteria checks 0/6
High Tide's earnings have been declining at an average annual rate of -18.6%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 45.7% per year.
Key information
-18.6%
Earnings growth rate
25.8%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | 45.7% |
| Return on equity | -20.9% |
| Net Margin | -6.0% |
| Last Earnings Update | 31 Jul 2024 |
Recent past performance updates
Recent updates
High Tide: Strategic Expansions Drive Impressive Growth While Remaining Undervalued
Dec 03High Tide: Higher Margins Are Now The Base Scenario
Jun 14High Tide's NuLeaf Naturals multicannabinoid products available for sale in Ontario
Oct 18High Tide to acquire Jimmy's Cannabis Shop BC for $5.3M
Sep 29High Tide GAAP EPS of -C$0.05, revenue of C$95.35M
Sep 14High Tide gets access to C$19M credit facility
Aug 18High Tide undertakes control of Three Kushbar locations in Alberta
Jul 28High Tide to raise C$10M in equity offering
Jul 19High tide opens first canna cabana store in British Columbia
Jul 13High Tide to acquire 9 retail cannabis stores from Choom for C$5.1M
Jul 07High Tide opens new Canna Cabana store in Sherwood Park
Jun 30'We Don't Need Legalization' - High Tide CEO Raj Grover
May 19Revenue & Expenses Breakdown
How High Tide makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jul 24 | 511 | -30 | 98 | 0 |
| 30 Apr 24 | 504 | -34 | 99 | 0 |
| 31 Jan 24 | 498 | -36 | 99 | 0 |
| 31 Oct 23 | 488 | -39 | 101 | 0 |
| 31 Jul 23 | 469 | -62 | 104 | 0 |
| 30 Apr 23 | 440 | -61 | 101 | 0 |
| 31 Jan 23 | 403 | -68 | 97 | 0 |
| 31 Oct 22 | 357 | -72 | 91 | 0 |
| 31 Jul 22 | 302 | -22 | 82 | 0 |
| 30 Apr 22 | 255 | -21 | 75 | 0 |
| 31 Jan 22 | 215 | -25 | 65 | 0 |
| 31 Oct 21 | 181 | -34 | 54 | 0 |
| 31 Jul 21 | 152 | -32 | 42 | 0 |
| 30 Apr 21 | 128 | -27 | 33 | 0 |
| 31 Jan 21 | 108 | -19 | 28 | 0 |
| 31 Oct 20 | 83 | -6 | 23 | 0 |
| 31 Jul 20 | 70 | -20 | 28 | 0 |
| 30 Apr 20 | 54 | -28 | 28 | 0 |
| 31 Jan 20 | 40 | -26 | 29 | 0 |
| 31 Oct 19 | 31 | -26 | 29 | 0 |
| 31 Jul 19 | 22 | -15 | 22 | 0 |
| 30 Apr 19 | 16 | -12 | 17 | 0 |
| 31 Jan 19 | 11 | -9 | 12 | 0 |
| 31 Oct 18 | 9 | -5 | 7 | 0 |
| 31 Jul 18 | 9 | -1 | 5 | 0 |
| 31 Oct 17 | 10 | 0 | 4 | 0 |
| 31 Oct 16 | 8 | 1 | 3 | 0 |
Quality Earnings: HITI is currently unprofitable.
Growing Profit Margin: HITI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HITI is unprofitable, and losses have increased over the past 5 years at a rate of 18.6% per year.
Accelerating Growth: Unable to compare HITI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HITI is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (54.6%).
Return on Equity
High ROE: HITI has a negative Return on Equity (-20.87%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 14:14 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/07/31 |
| Annual Earnings | 2023/10/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
High Tide Inc. is covered by 14 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Kideckel | ATB Capital Markets |
| Frederico Yokota Choucair Gomes | ATB Capital Markets |
| Doug Cooper | Beacon Securities Limited |